An enzyme-linked immunosorbent assay was developed to study the subclass distribution of immunoglobulin G (IgG) 
It is now accepted that acquired antibody responses toward given antigens may be limited to the preponderant production of one or certain determined immunoglobulin G (IgG) subclasses, with some biological activities controlled by the constant region (Fc fragment) of IgG varying from one subclass to another. On the other hand, Oxelius (11) and Schur et (19) have reported that in volunteers injected with dextran and levan, they detected only IgG2 antibodies against these antigens, even after periods of immunization as long as several years. Similarly, antibodies to hemophilic factor VIII appear to be restricted to the IgG4 subclass (1, 14) , and anti-Rh antibodies are predominantly of the IgGl subclass (18) . On the other hand, Morell et al. (9) have shown that antibodies toward hepatitis B surface antigen are predominantly of the IgGl and IgG3 subclasses, as they are in the case of other viral infections such as those caused by rubella virus (6) , cytomegalovirus (7) , and respiratory syncytial virus (4 
MATERIALS AND METHODS
Antigen. The procedure for the preparation, characterization, and purification of the CGL from S. minnesota R595 has been previously described (10) . Briefly, CGL was extracted from S. minnesota R595 by the phenol-chloroformpetroleum ether method (3) . Finally, the CGL antigen was characterized and purified by gel chromatography by the method described by Young et al. (18 Serum samples were taken from these patients on admission and thereafter every 7 days. In the present study, we selected specimens in which variations in the anti-CGL antigen IgG activities were observed in the anti-CGL ELISA previously described (10) .
In addition, we investigated serum specimens from healthy subjects who were found to be IgG positive toward the CGL antigen or negative, as determined by ELISA.
Purification of the human immunoglobulin subclasses. Human myeloma proteins IgGl, IgG2, IgG3, and IgG4 were purified from plasma by the technique described by Robbin and Wistar (12) (17) , which was slightly modified as described previously (10 In the ELISA for total anti-CGL IgG activity or in certain serum samples for subclass determinations, activities were expressed in terms of the endpoint titration given by the maximum dilution that gave an OD value that was significantly higher than that of a control serum sample without antigen. We considered negative those sera that gave a maximum active dilution of <1:200. The different ELISA curves obtained for each subclass activity were optimized by the program described by Feldman and Rodbard (2) .
Standardization of the assay and control of subclass specificity. The different human IgG subclasses that were purified were diluted at a concentration of 0.1 ,ug/ml and were used directly as the antigen. The assays were performed by using a checkerboard titration with twofold dilutions of each monoclonal antibody at dilutions that varied from 1:250 to 1:502,000. Optimal dilutions of the monoclonal antibodies, defined as those giving an absorbance of <0.3 in the absence of antigen and a specific OD value of about 1.2 with positive sera chosen as a standard, were 1:500 for anti-IgGl and anti-IgG2, 1:5,000 for anti-IgG3, and 1:16,000 for anti-IgG4.
Because the specific activity of some monoclonal antibodies has been shown to be influenced by different assay systems (5), we evaluated the specificity of the assay for each subclass by measuring the activity of each monoclonal antibody toward the various subclasses. In addition, we looked for the influence of the whole IgG subclasses on the activity of one of them by measuring activities of serum samples before and after fractions were pooled with sera displaying one or more elevated subclass activities toward the antigen. 
RESULTS
Determination of subclass specificity and reproducibility of the test. The activity of each monoclonal antibody was tested by establishing titration curves in assays in which IgGl, IgG2, IgG3, and IgG4 were used as antigens and coated in the plates at 0.5 ,ug/ml. We did not observe any significant cross-reactivity between a human IgG subclass and the other IgG subclasses at a monoclonal antibody dilution at which each IgG subclass was efficiently recognized by its related antibody, allowing us to assess for each subclass the specificity of the assay (Fig. 1) . In addition, several assays were performed by using sera with elevated anti-CGL activities due to one or two subclasses, which were investigated before and after they were mixed in the same proportions, to look for a possible competition effect between the whole subclass population and a defined subclass for the antigen. In all assays, the activity of each subclass was not significantly altered by the presence of the other subclasses. These control experiments were repeated with other mixtures of serum samples. By these assays, we never detected any competition effect. The value obtained for each subclass activity may therefore be considered intrinsic.
On the other hand, the reproducibility of the test was checked by repeated testing. The coefficients of variation of the optimal ODs were determined and found to be equal to 5 .1% for IgGl, 6 .9% for IgG2, 2.53% for IgG3, and 8.2% for IgG4.
Anti-CGL subclass activities in healthy blood donors. In an initial series of assays, we looked for anti-CGL IgG subclass activities in serum samples from 150 healthy blood donors of whom 52 (35%) were found by ELISA to be IgG positive toward the CGL antigen (10). 12. tive in the ELISA for IgG displayed a slight IgGl activity in the subclass-specific assay. This fact suggests that in some cases the subclass assays are somehow more sensitive than the ELISA for whole IgG. We explained this by considering the starting dilutions of the serum samples in both assays.
Twenty-nine individuals were found to be IgGl positive, and 19 had IgG3 activity. In nine individuals, we detected IgG1, IgG2, and IgG3 activities. None of the individuals had IgG4 activity, and we generally observed that IgG3 activities, if any, were relatively low with regard to IgG2 and IgGl, which were revealed to be predominant and to occur the most frequently in this group.
On the other hand, no differences in the distribution of the subclass activities were observed between males and females. Results of a representative series of experiments with sera from 20 individuals who were investigated for their subclass açtivities are given in Table 1 . Anti-CGL IgG subclass activities in patients displaying an acute gram-negative infection. The distribution of anti-CGL IgG activities determined by ELISA and subclass activities in patients on admission and during their hospitalization are reported in Tables 2 and 3 Thirty patients displayed at least a fourfold rise of their whole IgG activity (Table 3) . Only one of them died, which was from heart failure. The remaining 13 patients died of an infectious episode, leading to irreversible septic shock or organ failure. In 1 patient, we did not observe any IgG increase, and a significant decrease was demonstrated in the other 12 patients.
When the data in Tables 2 and 3 are compared, it appears that from the 30 patients with either a significant increase in IgG or an IgG seroconversion detected by ELISA, 5 acquired IgGl, 6 acquired 1gG3, and 4 acquired IgG4.
Generally, in the group of patients IgGl and IgG4 activities were found at relatively low levels, when compared with IgG2 and IgG3 activities, and were found at very low frequencies.
All patients displaying IgG4 activities had anti-CGL IgG activities of .1:800 as determined by ELISA on admission and during serological evolution. On the other hand, they all had positive blood cultures. These facts suggest that the development of an anti-CGL IgG4 activity may be considered as an indicator of active response toward a severe infection. However, three patients displayed a bacteremia without developing IgG4.
In addition we observed ( Fig. 2 and 3 ) that patients with a significant rise in total IgG activities also displayed an increased occurrence of IgG2 activities, as well as the apparition of IgG3 in 6 of the 30 patients. Moreover, IgG2 levels increased in all individuals (data not shown). This observation indicates that IgG2 and IgG3 are the main factors that determine the endpoint activity of the total anti-CGL IgG, as determined by ELISA, the activities of IgGl and IgG4 remaining relatively weak. Conversely, in 12 of the 13 patients who died, we observed a striking drop in anti-IgG2 activity, whereas activities of most of the other subclasses remained stable, with the exception of that in 1 patient, who lost IgG3 activity (Fig. 4) .
DISCUSSION
In this study we developed an ELISA for the detection of anti-CGL IgG subclass antibodies with the goal to improve the anti-CGL IgG ELISA that we had previously set up to carry out a study (10) 
